Adverum Biotech
Keith Mason has extensive experience in the biotechnology and biopharmaceutical industries, currently serving as a Senior Engineer I at Adverum Biotechnologies, Inc. since August 2018. Prior roles include Process Scientist 1 in Protein Sciences at Boehringer Ingelheim for a brief tenure in 2018, and Process Engineering Intern focused on AAV manufacturing processes at 4D Molecular Therapeutics. Keith Mason also worked at Genentech in various capacities, including CHO Bioprocess Technician, where responsibilities included training personnel and ensuring compliance. Additional experience includes a sales role at Bicycle Village and equipment preparation at Genentech. Keith Mason holds a Master’s degree in Bioengineering from the University of California, Berkeley, and a Bachelor’s degree in Biological Sciences from the University of California, Davis.
This person is not in the org chart
Adverum Biotech
9 followers
Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of its lead indication, wet age-related macular degeneration.